Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Quarter and half-year ended September 30, 2015 (Q2 and H1 FY16)
Filing Date: October 30, 2015
This filing serves to disclose the company's results of operations and financial condition for the specified period. The company announced these results on October 29, 2015, under International Financial Reporting Standards (IFRS).
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
Financial data is referenced as being available in the following attached exhibits:
- Exhibit 99.1: Press Release detailing Q2 and H1 FY16 Financial Results (IFRS).
- Exhibit 99.2: Indian GAAP Unaudited Standalone Financial Results.
- Exhibit 99.3: IFRS Unaudited Consolidated Financial Results.
Note: Specific financial figures are not present in the filing text provided.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) and financial statements (Exhibits 99.2 and 99.3) for comparative analysis.
Guidance, Outlook, and Risks
The text does not contain specific management commentary, guidance, outlook, risks, contingencies, or unusual items. These disclosures are contained within the attached exhibits referenced in the filing.
Investor Verification Checklist
- Review Exhibit 99.1 for the official press release and management commentary on Q2/H1 FY16 performance.
- Verify consolidated financial metrics in Exhibit 99.3 (IFRS Unaudited Consolidated Financial Results).
- Compare standalone results in Exhibit 99.2 (Indian GAAP) against consolidated figures to understand geographic or segment variances.
- Confirm the availability of the review reports mentioned as being attached to the financial results.